论文部分内容阅读
目的分析引起肝动脉栓塞治疗肝海绵状血管瘤的争议的原因。方法治疗肝血管瘤14例,瘤体大小为6cm×7cm￣12cm×14cm。采用Seldinger技术股动脉插管,导管超选择插至肝血管瘤供血动脉后,灌注平阳霉素碘化油乳剂及明胶海绵条栓塞肿瘤供血动脉。所有病例术后随访16个月￣24个月。结果14例临床症状消失,瘤体均缩小>80%,2例瘤体完全消失。未出现肝坏死及肝内胆管毁损等并发症。结论我们认为HAE治疗CHL,必须选择高流量和/或中等流量的CHL,同时插管一定到位,才能提高疗效,避免并发症,减少对HAE治疗CHL的争议。
Objective To analyze the causes of controversy about hepatic cavernous hemangioma caused by hepatic arterial embolization. Methods Hepatic hemangioma in 14 cases, the tumor size of 6cm × 7cm ~ 12cm × 14cm. Seldinger technique was used for femoral artery catheterization. The catheter was superselectively inserted into the hepatic hemangioma feeding artery and then perfused with bleomycin lipiodol emulsion and gelatin sponge to embolize the donor artery. All cases were followed up for 16 months ~ 24 months. Results 14 cases of clinical symptoms disappeared, the tumor were reduced> 80%, 2 cases completely disappeared. No liver necrosis and intrahepatic bile duct destruction and other complications occurred. Conclusions We believe that HAE for CHL treatment must choose high and / or moderate flow CHL, and intubation must be in place to improve the curative effect, avoid complications and reduce the controversy of treating CHL with HAE.